Uncover a potential systemic cause of dry eye before it takes hold.
Sjö is a diagnostic test that combines traditional and novel, proprietary biomarkers to create an advanced diagnostic panel for the early detection of Sjögren’s syndrome in your patients.
The early symptoms of Sjögren’s syndrome commonly present as routine dry eye.1
Sjögren’s syndrome affects up to 4 million people in the U.S.; most of whom are undiagnosed.1,2
Your patients’ dry eye symptoms may be rooted in a progressive autoimmune disease.
- Sjögren’s syndrome is a serious autoimmune disease that causes damage to the exocrine glands, which are responsible for producing moisture1,2,6
- There is an average delay of 10 years in receiving an accurate diagnosis3,4
- Early diagnosis can result in patients being monitored for organ-specific manifestations, general symptoms, associated autoimmune diseases and malignancies.
You may be positioned to help detect Sjögren’s syndrome earlier in your patients with the Sjö diagnostic kit.
Sjö—Early detection of Sjögren’s syndrome
- Combines 4 traditional biomarkers with 3 novel, propriety biomarkers
- Helps detect Sjögren’s syndrome early in its disease course
- Offers high specificity and significantly higher sensitivity than other screening methods
Sjö combines traditional and novel, proprietary biomarkers to create an advanced diagnostic panel:
Sjö : Additional information
1. Kassan SS, Moutsopoulos HM. Clinical manifestations and early diagnosis of Sjögren syndrome. Arch Intern Med. 2004;164:1275-1284.
2. Sjögren’s Syndrome Foundation. 2014. Available athttp://www.sjogrens.org/home/about-sjogrens-syndrome/diagnosis. Accessed February 2, 2015.
3. Akpek EK, Mathews P, Hahn S, et al. Ocular and systemic morbidity in a longitudinal cohort of Sjögren’s syndrome. Ophthalmology. 2015;122(1):56‐61.
4. García‐Carrasco M, Ramos‐Casals M, Rosas J, et al. Primary Sjögren syndrome: clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81(4):270‐280.
5. Liew M, Zhang M, Kim E, et al. Prevalence and predictors of Sjögren’s syndrome in a prospective cohort of patients with aqueous-deficient dry eye. Br J Ophthalmol. 2012;96:1498-1503.
6. Martin-Martin LS, Massafra U, Migliore A. Sjögren’s syndrome: an under-diagnosed disorder. CLI. May 2004.
7. Shen L, Suresh L, Lindemann M, et al. Novel autoantibodies in Sjögren’s syndrome. Clin Immunol. 2012;145:251-255.